1. Home
  2. TBPH vs AIV Comparison

TBPH vs AIV Comparison

Compare TBPH & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.77

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$4.24

Market Cap

837.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
AIV
Founded
2013
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
824.9M
837.1M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
TBPH
AIV
Price
$16.77
$4.24
Analyst Decision
Buy
Buy
Analyst Count
6
1
Target Price
$18.40
$10.00
AVG Volume (30 Days)
402.7K
1.4M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
87.00%
EPS Growth
279.13
616.00
EPS
2.06
3.87
Revenue
$15,386,000.00
$138,486,000.00
Revenue This Year
$8.46
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.15
$1.10
Revenue Growth
N/A
N/A
52 Week Low
$8.33
$3.94
52 Week High
$21.03
$8.87

Technical Indicators

Market Signals
Indicator
TBPH
AIV
Relative Strength Index (RSI) 56.91 50.39
Support Level $13.41 $4.03
Resistance Level $17.24 $4.28
Average True Range (ATR) 0.41 0.06
MACD 0.02 0.04
Stochastic Oscillator 57.01 85.37

Price Performance

Historical Comparison
TBPH
AIV

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.

Share on Social Networks: